SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

GUL Gullewa Limited

Basic Materials · Gold · website
$0.07
52wk 0.06 – 0.12
Overall
65.5
Value
88.5
Growth
50.0
Health
100.0
Quality
66.1
Momentum
7.9
Dividend
66.7
Price
About Gullewa Limited

Gullewa Limited engages in the exploration, evaluation, and mining of mineral properties in Australia. It operates in three segments: Exploration and Evaluation; Property Holding; and Investments. The company explores for gold and base metal deposits. It is also involved in land subdivision activity; acquires investment properties for development; and invests in shares of listed and unlisted entities, as well as involves in mineral royalties. Gullewa Limited was incorporated in 1953 and is based in Sydney, Australia.

Commodity exposure

Primary exposure: Gold (detected from the company profile: gold)

Gold primary
4,213.80 USD/oz
1m: -3.5% · 1y: 9.7%
Price analytics

Returns

1 day 0.0%
1 week -9.2%
1 month -16.9%
3 months 3.0%
6 months -25.0%
1 year -18.8%
3 years 25.5%

Risk

Volatility (1y ann.) 61.6%
Beta vs ASX 200 0.31
Sharpe (1y) -0.09
VaR 95% (1-day) -6.1%
Max drawdown (1y) -46.7%
Off 1-year high -42.5%

Technicals

RSI(14) 37
vs 50DMA -4.1%
vs 200DMA -19.8%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 88.5
Trailing P/E
100
Forward P/E
—
PEG ratio
—
EV / EBITDA
82
Price / Book
100
Price / Sales
68
Growth 50.0
Revenue growth (1y)
0
Revenue CAGR (3y)
—
EPS growth (1y)
100
EPS CAGR (3y)
—
Financial Health 100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
—
Quality (Profitability & Cash Flow) 66.1
Return on equity
21
Return on assets
53
Operating margin
100
Net margin
100
Cash conversion (OCF / net income)
—
Dividend / Income 66.7
Dividend yield (%)
100
Payout ratio
33
FCF dividend cover
—
Momentum 7.9
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
29
Position in 52-week range
8

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$15.04M
P/E (trailing)
6.90
P/E (forward)
—
EPS (trailing)
0.01
Dividend yield
10.1%
Payout ratio
93.3%
Beta
—
EV / EBITDA
6.83
Price / Book
0.77
ROE
4.2%
Operating margin
32.6%
Net margin
30.1%
Total cash
$3.05M
Total debt
$0
Current ratio
7.12
Debt / Equity
—
Free cash flow
$-9.77M
Avg volume
79,678
Latest annual results (FY ending 30 Jun 2024)
  • Revenue—
  • Gross profit—
  • Operating income-$1.71M
  • Net income$2.19M
  • Diluted EPS0.01
  • Free cash flow$2.16M
  • Net debt-$8.55M
Sector peers (Basic Materials)
TickerMkt cap P/EScore
BHP $311.13B 22.0 68.1
RIO $268.04B 15.5 58.1
NEM $174.41B 14.5 82.2
FMG $49.85B 12.1 60.7
NST $34.22B 20.7 76.0
EVN $26.76B 17.9 79.4
S32 $22.08B 14.5 67.1
JHX $20.94B 112.7 45.6